Spanish pharmaceutical firm Grifols saw its shares surge by 11% on Thursday, following a significant rise in its third-quarter net ...

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article titled “The CNMV reveals to the judge ‘continuous ...

Carson Block of Muddy Waters announced Grifols (GRFS) as a short idea for the Robin Hood contest, according to Bloomberg. Published first on TheFly – the ultimate source for real-time ...

Immunoglobulin therapy improves mobility in phase 2/3 study Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous immunoglobulin ...

The net impact on the market is typically positive. Take Gotham City Research LLC’s dramatic assault on Grifols SA in January last year. The US hedge fund’s diatribe against the Spanish ...

Investing.com – Spain stocks were lower after the close on Thursday, as losses in the Financial Services & Real Estate, Consumer ...

Hamilton was declared a paid-plasma-free zone in June, but Canadian Blood Services and Spanish health-care company Grifols are going ahead anyway with the centre in a lower-income area at 2255 ...

Private equity firm Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's share price. The Canadian investment group said it ...

In this article, we are going to take a look at where Grifols, S.A. (NASDAQ:GRFS) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

Papua New Guinea (PNG) is richly endowed with natural resources, but exploitation has been hampered by rugged terrain, land tenure issues, and the high cost of developing infrastructure. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...